3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
21
Myelodysplastic Syndromes
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Myeloproliferative Disorders
6
Lymphoma, Non-Hodgkin
5
Leukemia
5
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Hodgkin Disease
4
Anemia, Refractory, with Excess of Blasts
4
Multiple Myeloma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Graft vs Host Disease
3
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Preleukemia
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurofibromatosis 1
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Busulfan
×
90 days
×
Clear all
No trials found.